New developments in the treatment of cryptococcal disease in AIDS

Rifabutin induced vitritis in AIDS patients.

Ocular immunology and inflammation·2012

Progenitor cell types in HIV-1 infection: bioactivity and emerging targets for treatment.

Current HIV research·2009

Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.

HIV medicine·2009

European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV.

HIV medicine·2008

Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease?

HIV medicine·2007

Predictors of immunity after hepatitis A vaccination in HIV-infected persons.

Journal of viral hepatitis·2007

Reconstitution of immunity against opportunistic infections in the era of potent antiretroviral therapy.

AIDS clinical review·2000

Pediatric human immunodeficiency virus type 1 infection: updates on prevention and management.

AIDS clinical review·2000

Disseminated Mycobacterium avium complex infection: implications of recent clinical trials on prophylaxis and treatment.

AIDS clinical review·1997

Cytokines and cytokine therapies in HIV infection.

AIDS clinical review·1997

Pediatric HIV disease: new developments in treatment and prevention.

AIDS clinical review·1997

The epidemiology of HIV and AIDS in the United States.

AIDS clinical review·1997

Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease.

Bioactive materials·2026

Research advances in microneedle-exosome delivery systems for the treatment of multisystem diseases.

Regenerative therapy·2026

GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease.

Molecular therapy. Advances·2026

Integrating kidney imaging for risk prediction, therapeutic monitoring, and prognostication across the kidney disease spectrum: a review of emerging evidence.

Clinical kidney journal·2026

Advances in peptide-based nanostrategies against drug-resistant bacteria: Natural amino acids to molecular modifications.

Biotechnology advances·2026

Systematic review of the mutations in the active antigenic site Ø of the prefusion F protein of the Respiratory Syncytial Virus (RSV) following the implementation of monoclonal antibody prophylaxis.

Vaccine·2026

Related Experiment Videos

New developments in the treatment of cryptococcal disease in AIDS

Related Concept Videos

Rifabutin induced vitritis in AIDS patients.

Progenitor cell types in HIV-1 infection: bioactivity and emerging targets for treatment.

Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.

European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV.

Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease?

Predictors of immunity after hepatitis A vaccination in HIV-infected persons.

Reconstitution of immunity against opportunistic infections in the era of potent antiretroviral therapy.

Pediatric human immunodeficiency virus type 1 infection: updates on prevention and management.

Disseminated Mycobacterium avium complex infection: implications of recent clinical trials on prophylaxis and treatment.

Cytokines and cytokine therapies in HIV infection.

Pediatric HIV disease: new developments in treatment and prevention.

The epidemiology of HIV and AIDS in the United States.

Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease.

Research advances in microneedle-exosome delivery systems for the treatment of multisystem diseases.

GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease.

Integrating kidney imaging for risk prediction, therapeutic monitoring, and prognostication across the kidney disease spectrum: a review of emerging evidence.

Advances in peptide-based nanostrategies against drug-resistant bacteria: Natural amino acids to molecular modifications.

Systematic review of the mutations in the active antigenic site Ø of the prefusion F protein of the Respiratory Syncytial Virus (RSV) following the implementation of monoclonal antibody prophylaxis.

Related Experiment Videos

New developments in the treatment of cryptococcal disease in AIDS

Related Concept Videos

Related Articles